Hyperuricemia and metabolic syndrome: Associations with chronic kidney disease

Clinical Rheumatology

Volumn 30, Issue 3, 2011, Pages 323-330

  See, Lai Chu ^a   Kuo, Chang Fu ^a   Chuang, Fang Hsiu ^a   Shen, Yu Ming ^a   Ko, Yu Shien ^b   Chen, Yu Ming ^a   Yu, Kuang Hui ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Chronic kidney disease; Hyperuricemia; Metabolic syndrome; Uric acid

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; DIASTOLIC BLOOD PRESSURE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERURICEMIA; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PREVALENCE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TAIWAN; URIC ACID BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; CHRONIC DISEASE; FEMALE; HUMANS; HYPERURICEMIA; KIDNEY DISEASES; MALE; METABOLIC DISEASES; MIDDLE AGED;

EID: 79954571306     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-010-1461-z     Document Type: Article

References (52)

1. K/DOQI 2002 Clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification Am J Kidney Dis 39 S1 S266 10.1016/S0272-6386(02)70081-4
2. Wortmann RL, Kelley WN (2005) Gout and hyperuricemia. In: Kelley WN, Harris ED, Ruddy S, Sledge CB (eds) Textbook of rheumatology, 7th edn. W.B. Saunders, Philadelphia, pp 1402-1448
3. Becker MA, Jolly M (2005) Clinical gout and the pathogenesis of hyperuricemia. In: Koopman WJ (ed) Arthritis and allied conditions, 15th edn. Williams & Wilkins, Baltimore, pp 2303-2339
4. K Iseki S Oshiro M Tozawa, et al. 2001 Significance of hyperuricemia on the early detection of renal failure in a cohort of screened subjects Hypertens Res 24 691 697 11768729 10.1291/hypres.24.691 1:STN:280:DC%2BD38%2FktFWqsg%3D%3D (Pubitemid 33133783)
5. YC Chen CT Su ST Wang, et al. 2009 A preliminary investigation of the association between serum uric acid and impaired renal function Chang Gung Med J 32 66 71 19292941
6. DE Weiner H Tighiouart EF Elsayed, et al. 2008 Uric acid and incident kidney disease in the community J Am Soc Nephrol 19 1204 1211 18337481 10.1681/ASN.2007101075 1:CAS:528:DC%2BD1cXns1yiu78%3D
7. P Cirillo W Sato S Reungjui M Heinig, et al. 2006 Uric acid, the metabolic syndrome, and renal disease J Am Soc Nephrol 17 S165 S168 17130256 10.1681/ASN.2006080909 1:CAS:528:DC%2BD28XhtlCntL3P (Pubitemid 44865243)
8. V Lohsoonthorn B Dhanamun MA Williams 2006 Prevalence of hyperuricemia and its relationship with metabolic syndrome in Thai adults receiving annual health exams Arch Med Res 37 883 889 16971230 10.1016/j.arcmed.2006.03.008 1:CAS:528:DC%2BD28XpsVWmu7o%3D (Pubitemid 44333145)
9. HK Choi ES Ford 2007 Prevalence of the metabolic syndrome in individuals with hyperuricemia Am J Med 120 442 447 17466656 10.1016/j.amjmed.2006.06.040 (Pubitemid 46656248)
10. SD Lin DH Tsai SR Hsu 2006 Association between serum uric acid level and components of the metabolic syndrome J Chin Med Assoc 69 512 516 17116612 10.1016/S1726-4901(09)70320-X 1:CAS:528:DC%2BD2sXitFCitQ%3D%3D
11. ES Ford C Li S Cook HK Choi 2007 Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents Circulation 115 2526 2532 17470699 10.1161/CIRCULATIONAHA.106.657627 1:CAS:528:DC%2BD2sXltVSms70%3D (Pubitemid 46763226)
12. TW Yoo KC Sung HS Shin, et al. 2005 Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome Circ J 69 928 933 16041161 10.1253/circj.69.928 1:CAS:528:DC%2BD2MXpsVamtLg%3D (Pubitemid 41124260)
13. J Chen P Muntner LL Hamm, et al. 2004 The metabolic syndrome and chronic kidney disease in US adults Ann Intern Med 140 167 174 14757614
14. M Kurella JC Lo GM Chertow 2005 Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults J Am Soc Nephrol 16 2134 2140 15901764 10.1681/ASN.2005010106 (Pubitemid 41716445)
15. YC Ma L Zuo JH Chen, et al. 2006 Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease J Am Soc Nephrol 17 2937 2944 16988059 10.1681/ASN.2006040368 (Pubitemid 44484685)
16. AS Levey JP Bosch JB Lewis, et al. 1999 A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group Ann Intern Med 130 461 470 10075613 1:CAS:528:DyaK1MXitFChs7k%3D (Pubitemid 29135798)
17. DR James CP Price 1984 Problem associated with the measurement of uric acid using two enzyme-mediated reaction systems Ann Clin Biochem 21 405 410 6508211 1:CAS:528:DyaL2cXlvVOiurw%3D (Pubitemid 14028920)
18. K Spencer 1986 Analytic reviews in clinical biochemistrythe estimation of creatinine Ann Clin Biochem 23 1 25 3532908 1:CAS:528:DyaL28Xht1GrsL8%3D (Pubitemid 16178799)
19. HY Chang WH Pan WT Yeh, et al. 2001 Hyperuricemia and gout in Taiwan: results from the Nutritional and Health Survey in Taiwan (1993-96) J Rheumatol 28 1640 1646 11469473 1:STN:280:DC%2BD38%2Fit1yjsg%3D%3D
20. KH Yu LC See YC Huang, et al. 2008 Dietary factors associated with hyperuricemia in adults Semin Arthritis Rheum 37 243 250 17570471 10.1016/j.semarthrit.2007.04.007 1:CAS:528:DC%2BD1cXhtV2is7o%3D (Pubitemid 351146592)
21. CE Tan S Ma D Wai, et al. 2004 Can we apply the national cholesterol education program adult treatment panel definition of the metabolic syndrome to Asians? Diab Care 27 1182 1186 10.2337/diacare.27.5.1182 (Pubitemid 38579787)
22. Bureau of Health Promotion, Department of Health, Taiwan. The criteria of metabolic syndrome. Available for download from http://www.bhp.doh.gov.tw/asp/ news/file/2005125154090XP3WQ/0931012 Accessed 30 Sep 2009
23. AV Chobanian GL Bakris HR Black, et al. 2003 The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report JAMA 289 2560 2572 12748199 10.1001/jama.289.19.2560 1:CAS:528:DC%2BD3sXjvFCqtrk%3D (Pubitemid 37430158)
24. Zar JH (1999) Biostatistical analysis, 4th edn. Prentice-Hall, New Jersey, pp 563-564, appendix 64
25. T Nakagawa P Cirillo W Sato, et al. 2008 The conundrum of hyperuricemia, metabolic syndrome, and renal disease Intern Emerg Med 3 313 318 18320146 10.1007/s11739-008-0141-3
26. RJ Johnson MS Segal Y Sautin, et al. 2007 Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease Am J Clin Nutr 86 899 906 17921363 1:CAS:528:DC%2BD2sXhtFyks7vJ (Pubitemid 47538288)
27. AM Fishberg 1924 The interpretation of increased blood uric acid in hyertension Arch Int Med 34 503 507 1:CAS:528:DyaB2MXitFyl
28. AP Hall PE Barry TR Dawber, et al. 1967 Epidemiology of gout and hyperuricemia. A long-term population study Am J Med 42 27 37 6016478 10.1016/0002-9343(67)90004-6 1:STN:280:DyaF2s%2FosVWhtw%3D%3D
29. RJ Glynn EW Campion JE Silbert 1983 Trends in serum uric acid levels 1961-1980 Arthritis Rheum 26 87 93 6824508 10.1002/art.1780260115 1:STN:280:DyaL3s7is1OisQ%3D%3D (Pubitemid 13175206)
30. WM Mikkelsen HJ Dodge HA Valkenburg, et al. 1965 The distribution of serum uric acid values in a population unselected as to gout or hyperuricemia, Tecumseh, Michigan, 1959-1960 Am J Med 39 242 251 14320691 10.1016/0002-9343(65) 90048-3 1:STN:280:DyaF2M7isFeltg%3D%3D
31. IF Duff WM Mikkelsen HJ Dodge, et al. 1968 Comparison of uric acid levels in some Oriental and Caucasian groups unselected as to gout or hyperuricemia Arthritis Rheum 11 184 190 5645731 10.1002/art.1780110209 1:STN:280: DyaF1c7pslWmug%3D%3D
32. M Chonchol MG Shlipak R Katz, et al. 2007 Relationship of uric acid with progression of kidney disease Am J Kidney Dis 50 239 247 17660025 10.1053/j.ajkd.2007.05.013 1:CAS:528:DC%2BD2sXhtVSiu7rK (Pubitemid 47095076)
33. F Facchini YD Chen CB Hollenbeck, et al. 1991 Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration JAMA 266 3008 3011 1820474 10.1001/jama.266.21. 3008 1:CAS:528:DyaK38Xls1yrtLg%3D
34. H Vuorinen-Markkola H Yki-Järvinen 1994 Hyperuricemia and insulin resistance J Clin Endocrinol Metab 78 25 29 8288709 10.1210/jc.78.1.25 1:STN:280:DyaK2c7hslKhsw%3D%3D (Pubitemid 24026741)
35. A Dehghan M van Hoek EJ Sijbrands, et al. 2008 High serum uric acid as a novel risk factor for type 2 diabetes Diab Care 31 361 362 10.2337/dc07-1276 1:CAS:528:DC%2BD1cXis1ajs7s%3D (Pubitemid 351213351)
36. X Sui TS Church RA Meriwether, et al. 2008 Uric acid and the development of metabolic syndrome in women and men Metabolism 57 845 852 18502269 10.1016/j.metabol.2008.01.030 1:CAS:528:DC%2BD1cXmsVaqtL8%3D (Pubitemid 351697915)
37. ET Rosolowsky LH Ficociello NJ Maselli, et al. 2008 High-normal serum uric acid is associated with impaired glomerular filtration rate in nonproteinuric patients with type 1 diabetes Clin J Am Soc Nephrol 3 706 713 18272826 10.2215/CJN.04271007 1:CAS:528:DC%2BD1cXhtVamtLnE
38. JL Lin PS Lim 1992 Elevated lead burden in Chinese patients without occupational lead exposure Miner Electrolyte Metab 18 1 5 1406500 1:CAS:528:DyaK3sXitFCh
39. JL Lin DT Tan HH Ho, et al. 2002 Environmental lead exposure and urate excretion in the general population Am J Med 113 563 568 12459402 10.1016/S0002-9343(02)01296-2 1:CAS:528:DC%2BD38XovFGquro%3D (Pubitemid 35379911)
40. LH Lai SY Chou FY Wu, et al. 2008 Renal dysfunction and hyperuricemia with low blood lead levels and ethnicity in community-based study Sci Total Environ 401 39 43 18514766 10.1016/j.scitotenv.2008.04.004 1:CAS:528: DC%2BD1cXntl2lsLw%3D
41. NA Shadick R Kim S Weiss, et al. 2000 Effect of low level lead exposure on hyperuricemia and gout among middle aged and elderly men: the normative aging study J Rheumatol 27 1708 1712 10914856 1:STN:280:DC%2BD3M%2FitlyltA%3D%3D (Pubitemid 30462816)
42. JL Lin CC Yu DT Lin-Tan, et al. 2001 Lead chelation therapy and urate excretion in patients with chronic renal diseases and gout Kidney Int 60 266 271 11422760 10.1046/j.1523-1755.2001.00795.x 1:CAS:528:DC%2BD3MXltlKnurY%3D (Pubitemid 32587563)
43. JL Lin DT Tan KH Hsu, et al. 2001 Environmental lead exposure and progressive renal insufficiency Arch Intern Med 161 264 271 11176742 10.1001/archinte.161.2.264 1:CAS:528:DC%2BD3MXps1SisA%3D%3D
44. IH Fox WN Kelley 1974 Studies on the mechanism of fructose-induced hyperuricemia in man Adv Exp Med Biol 41 463 470 4364978 1:STN:280: DyaE2c7nslajug%3D%3D
45. T Nakagawa H Hu S Zharikov, et al. 2006 A causal role for uric acid in fructose-induced metabolic syndrome Am J Physiol Ren Physiol 290 F625 F631 10.1152/ajprenal.00140.2005 1:CAS:528:DC%2BD28XjtFCnsbY%3D (Pubitemid 43724964)
46. LG Sánchez-Lozada E Tapia P Bautista-García, et al. 2008 Effects of febuxostat on metabolic and renal alterations in rats with fructose-induced metabolic syndrome Am J Physiol Ren Physiol 294 F710 F718 10.1152/ajprenal.00454.2007
47. LG Sánchez-Lozada E Tapia A Jimenez, et al. 2007 Fructose-induced metabolic syndrome is associated with glomerular hypertension and renal microvascular damage in rats Am J Physiol Ren Physiol 292 F423 F429 10.1152/ajprenal.00124.2006 (Pubitemid 46105280)
48. MC Ryan HM Fenster Farin F Abbasi, et al. 2008 Comparison of waist circumference versus body mass index in diagnosing metabolic syndrome and identifying apparently healthy subjects at increased risk of cardiovascular disease Am J Cardiol 102 40 46 18572033 10.1016/j.amjcard.2008.02.096
49. WH Pan KM Flegal HY Chang, et al. 2004 Body mass index and obesity-related metabolic disorders in Taiwanese and US whites and blacks: implications for definitions of overweight and obesity for Asians Am J Clin Nutr 79 31 39 14684394 1:CAS:528:DC%2BD2cXhsFyltw%3D%3D (Pubitemid 41132059)
50. YC Lin LL Yen SY Chen, et al. 2003 Prevalence of overweight and obesity and its associated factors: findings from National Nutrition and Health Survey in Taiwan, 1993-1996 Prev Med 37 233 241 12914829 10.1016/S0091-7435(03)00119-1 (Pubitemid 36945560)
51. WHO Expert Consultation 2004 Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies Lancet 363 157 163 10.1016/S0140-6736(03)15268-3 (Pubitemid 38068335)
52. D Feig S Kivlighn J Kanellis, et al. 2003 Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 41 1183 1190 12707287 10.1161/01.HYP.0000069700.62727.C5 (Pubitemid 36706063)